Abstract Metabolic syndrome (MetS) is a clinical condition that includes multiple cardiovascular disease risk factors, including obesity, high blood pressure or hypertension, dyslipidemia, and abnormal glucose metabolism. The core metabolic abnormality in MetS is insulin resistance, or impaired insulin-mediated glucose regulation that results in elevated plasma insulin concentration. MetS greatly increases the risk for diabetes, atherosclerosis, and adverse metabolic and cardiovascular outcomes. The syndrome is present in over 25 % of adults in the U.S., with higher rates among racial/ethnic minority groups. Although commonly associated with adult diseases and aging, MetS has also been described in children and adolescents, but at a much lower prevalence of approximately 4-5 %. Because obesity is a key component of the syndrome, the growing childhood epidemic has raised awareness of MetS in children. The rate of MetS among obese children and adolescents is approximately 30 %, with similar racial/ethnic disparity among minority groups as among adults.
Introduction
An overlap in the occurrence of obesity, hypertension, type 2 diabetes, and atherosclerosis among adults has been commonly observed in clinical practice. This cluster of conditions and risk factors within individuals was first described as syndrome X by Reaven [1] in the 1988 Banting lecture. Other names were subsequently applied to this condition, including insulin resistance syndrome, mixed metabolic syndrome, dysmetabolic syndrome, and finally, metabolic syndrome (MetS), the term currently used. As proposed by Reaven and others [2, 3] , insulin resistance, or impaired insulin-mediated glucose uptake, is the core factor linking the various metabolic and hemodynamic abnormalities in MetS. As a consequence of tissue resistance to insulin action, greater amounts of insulin are secreted to achieve glucose control, resulting in relative hyperinsulinemia. Insulin resistance or impaired insulin sensitivity is difficult to quantify clinically, and the concept of MetS has developed as a strategy to identify individuals with multiple cardiovascular disease risk factors that are associated with insulin resistance. Individuals with MetS experience a high incidence of both diabetes and cardiovascular disease [4, 5] , and MetS is strongly associated with higher cardiovascular and total mortality [6] .
In the years since the syndrome was originally described, while there has been an expansion of knowledge with regard to the pathogenesis of metabolic and vascular alterations in MetS, several questions remain unanswered. For example, while obesity is a very consistent component of the condition, it is unclear if obesity is a cause or a consequence of MetS. Despite several theories and considerable study, the mechanism that links high blood pressure, or hypertension, with insulin resistance is still not well understood. There are racial and ethnic differences in the prevalence of the syndrome. Moreover, MetS is not limited to adults, and has been described in children and adolescents as well. This review will focus on racial/ethnic variations in MetS in adults and in children, with an emphasis on recent reports that link insulin resistance with high blood pressure in children and adolescents.
Definition of MetS
MetS is a cluster of cardiovascular disease risk factors associated with insulin resistance that increase the risk for diabetes, cardiovascular disease, and adverse cardiovascular outcomes [7, 8] . There are differences of opinion as to the precise definition of MetS, including the risk factors that are considered to be key components of the syndrome and what threshold values are characterized as abnormal. Definitions of MetS have been established by the World Health Organization (WHO) [9] , the European Group for the Study of Insulin Resistance [10] , the National Cholesterol Education Program Adult Treatment Panel III (ATPIII) [11] , the American Association of Clinical Endocrinologists [12] , and the International Diabetes Federation [13] . Of the various definitions, the WHO and ATPIII criteria appear to be more commonly used in clinical reports. Table 1 provides the WHO and ATPIII parameters. The ATPIII guidelines require three of the five listed criteria for diagnosis of MetS. The WHO guidelines require hyperinsulinemia, diabetes, or abnormal fasting glucose, plus two other criteria. In light of these variations in defining of MetS in adults, it has been difficult to compare the prevalence of MetS among different populations, especially with regard to ethnic and racial groups. Moreover, no consistent criteria have been established for childhood MetS [14] . Studies have generally been based on modifications of either WHO or ATPIII adult criteria. Goodman et al [15] compared the prevalence of MetS in a school-based sample of adolescents using the WHO versus the ATPIII definitions. With ATPIII criteria, overall prevalence among adolescents was 4.2 %, compared to 8.4 % with WHO criteria. Among obese adolescents, the prevalence of MetS was 19.5 % versus 38.9 % based upon ATPIII and WHO criteria, respectively. No differences in prevalence for race or sex were identified using ATPIII criteria, while differences were detected based upon the WHO definition. Obesity is a uniform parameter in all definitions of MetS, although criteria vary according to the measurement of adiposity used to determine risk: body mass index (BMI), waist circumference, or some other measurement of visceral adiposity. Despite this lack of uniformity, however, MetS is identifiable in children and adolescents [16] [17] [18] [19] . The global obesity epidemic, and particularly childhood obesity, has raised awareness and concern with regard to early expression of obesity-associated risk factors represented in MetS.
Prevalence of MetS by Race/Ethnicity
The prevalence of MetS in U.S. adults has been described in several reports based upon analysis of the National Health and Nutrition Examination Survey (NHANES) data [20, 21, 22••] . The first of these reports, based upon NHANES data from 1988-1994, estimated total age-adjusted prevalence of MetS of 23.97 %, using ATPIII criteria [21] . The most recent report by Beltran-Sanchez et al. [ These results indicate that approximately one in five U.S. adults currently meets the criteria for MetS, and the prevalence increases with age in all racial/ethnic groups. In comparisons by race/ethnicity, the decrease was statistically significant only for the white population (25.6 % to 21.8 %, p=0.009), and there was little change in prevalence among blacks and Hispanics (22.0 % vs. 22.71 % and 32.6 % vs. 31.9 %, respectively). These differences are summarized in Figure 1 . Notably, nearly onethird of Hispanics met the criteria for MetS in 2009-2010. Analysis of NHANES data between 1999-2000 and 2009-2010 demonstrate significant differences in trends within individual components of MetS and also substantial racial/ ethnic differences in several individual components. Notable differences in trends for race and sex were detected for abdominal obesity (Fig. 2 ) and abnormal glucose (Fig. 3) . The prevalence of visceral obesity in males, based on waist circumference >100 cm, increased for all adult males but was statistically significant only in white males (p=0.024). The prevalence of visceral obesity, based on waist circumference >88 cm, also increased for all females. Black and Hispanic females had the highest prevalence of visceral obesity. The increase in prevalence of visceral obesity was not statistically significant for Hispanic females [22••] . Overall, this analysis of the NHANES data indicates an extremely high prevalence of obesity based on waist circumference, nearly 50 % for males and over 60 % in all race/ethnic groups.
Somewhat different levels of obesity are reported when a different measure of obesity is applied to more recent NHANES data. Ogden et al. [23] analyzed the population prevalence of obesity using NHANES 2011 and 2012 data, but defined obesity as BMI >30 kg/m 2 . Overall, and for all racial groups with the exception of Asian-Americans, the prevalence of obesity exceeded 30 %. The age-adjusted prevalence was highest among Hispanic women (44.4 %) and black women (56.6 %). The report also included an analysis of obesity in children. Results indicated that while there were differences in the prevalence of obesity in pediatric groups according to race (19.6 % for white children, 22.1 % for black children, and 22.6 % for Hispanic children) racial/ethnic differences were more divergent in adults. Overall, the prevalence of obesity is extremely high in adults, whether defined by BMI or waist circumference, and similar racial/ethnic differences can be observed.
Abnormal glucose metabolism In a comparison of the 1999-2000 and 2009-2010 NHANES data, Beltran-Sanchez et al. [22••] reported that the prevalence of abnormal fasting glucose or diabetes increased in all racial/ethnic groups: from 12.3 % to 18.8 % in whites (p<0.001), 17.0 % to 21.8 % in blacks (p= 0.006), and 18.8 % to 29.8 % in Hispanics (p<0.001). The increase was statistically significant for all males and for white females, but was insignificant for black and Hispanic females. Dyslipidemia Similar to blood pressure, there appeared to be a reduction in the prevalence of abnormal high-density lipoprotein (HDL) cholesterol in the 2009-2010 NHANES data among whites compared to the 1999-2000 period. During the same time frame there was no significant change in the prevalence of abnormal HDL among blacks or Hispanics. The prevalence of abnormal HDL was 29.7 % for whites; lowest, at 27.1 %, for blacks; and highest among Hispanics, at 34.5 %. Overall, more than 25 % of white and black Americans and more than one-third of Hispanics met the criteria for low HD cholesterol (HDL-C).
Over this same period, there was a decline in the prevalence of elevated triglyceride levels in whites but no significant trend in blacks or Hispanics. In 2009-2010, more than onethird of Hispanics (35.7 %) had elevated triglycerides, and blacks had the lowest prevalence of elevated triglycerides The leading theory to explain the mechanism underlying the detrimental effect of insulin resistance on cardiovascular injury is the association of insulin resistance with atherosclerotic dyslipidemia [24] . Several reports describe greater insulin resistance in blacks compared to whites [25] [26] [27] . Despite this, blacks had more favorable lipid profiles compared to whites, with lower triglyceride (TG) and higher HDL-C concentrations [28, 29] . In a study on young black adults (age 30-45 years) in the U.S., significant correlations were found for TG, HDL-C, and TG/HDL-C ratio with insulin resistance, as quantified by the insulin clamp procedure. Despite obesity in 50 % of the sample, only 10 % of participants had plasma TG levels >150 mg/dL, the MetS criterion for both ATPIII and WHO. Participants with TG levels of 110-149 mg/dL had measures of insulin resistance comparable to those with TG >150 mg/dL [30] . Although black Americans appear to have more favorable lipid profiles, it is possible that they have a different threshold for adverse effects of relative dyslipidemia. Oxidative stress may be a plausible pathway for lipid-mediated vascular injury. Lopes et al. studied the effect of acute hyperlipidemia on oxidative stress in black and white populations in the U.S. [31] . In both groups, a comparable increase in plasma TG concentration occurred following an infusion of Intralipid and heparin. However, F2-isoprostanes, a biomarker of oxidative stress in humans, was significantly higher in blacks compared to whites. Although this report was based on a short-term rise in TG, the results suggest that blacks may have greater sensitivity to increases in TG. Some reports on the prevalence of MetS based on studies that include various racial groups question the validity of applying the same criteria to all races and ethnicities [32, 33] .
As noted above, the population prevalence of MetS varies considerably depending upon the definition applied, and this is especially true for estimated prevalence of MetS in children and adolescents. An early report on the prevalence of childhood MetS by Cook et al. [34] used ATPIII criteria to estimate the prevalence of MetS in adolescents based upon the NHANES 1988-1994 data, noting an overall prevalence of Fig. 3 The age-adjusted prevalence of elevated plasma glucose levels in adult males and females is depicted for racial/ ethnic populations. The racial/ ethnic prevalence of elevated glucose is compared in two NHANES data periods: 1999-2000 in black bars and 2009-2010 in gray bars. The prevalence data is based on an analysis of serial NHANES data by Beltrán-Sánchez et al. [22] 4.2 %, with rates higher in boys than girls. Among obese adolescents only, the prevalence was 28.7 %. A study by Weiss et al. [16] , which included predominantly obese children 4-20 years of age, used a combination of ATPIII and WHO criteria to define MetS. The authors reported a progressive rise in the prevalence of MetS with increasing degree of obesity and insulin resistance, with MetS identified in 50 % of severely obese youth. Subsequently, Cook et al. [35] used four different definitions and the NHANES 1999-2000 data to compute the prevalence of MetS in adolescents. Depending upon the criteria used, the overall prevalence ranged from 2.0 % to 9.4 %., and 12 % to 44 % among obese adolescents. In another report, Ford et al. [36] used the International Diabetes Federation criteria to estimate the prevalence of MetS in adolescents for three NHANES data periods from 1999-2000 to [2003] [2004] , reporting an overall prevalence of 4.5 %. There were variations according to age, sex, and race, with the highest rate of MetS (7.1 %) among Hispanics. As in adults, variations in reported childhood prevalence of MetS are based upon the defining criteria. In addition, the NHANES 1988-1994 data precedes the childhood obesity epidemic, while the epidemic was well underway in the 1999-2000 data period. Nonetheless, the data consistently demonstrate higher prevalence of MetS among obese children relative to their non-obese counterparts.
Obesity-Associated Hypertension
Obesity is commonly associated with hypertension in adults, and this strong correlation is consistent across all racial/ethnic groups. Campbell et al. [37] reported on a study designed to determine whether the combination of obesity and high blood pressure (BP) might be a clinical phenotype for MetS among blacks in the U.S. The investigators stratified a sample of 337 young adult black men (mean age 32 years) into four BP-BMI categories: non-obese and normal BP, non-obese and high BP, obese and normal BP, obese and high BP. All participants had fasting lipid level and oral glucose tolerance tests and an insulin clamp procedure to quantify insulin resistance. ATPIII criteria were used to identify MetS within each group. No cases of MetS were present among non-obese participants with normal BP. The presence of high BP without obesity was associated with 25 % prevalence of MetS, and obesity with normal BP was associated with 44.9 % prevalence. In the obese/high BP group, already having met two MetS criteria, 87 % had at least one lipid or glucose abnormality, thereby meeting the criteria for MetS. Among the obese participants, the degree of insulin resistance was comparable in those with and without high BP. Interestingly, previously unknown type 2 diabetes was identified in 19.2 % of the obese/high BP group, compared to 0 %-2.6 % in the other three groups.
Although the study was limited to black Americans, the results suggest that the combination of obesity and high BP increases the risk for additional metabolic abnormalities.
While the prevalence of primary hypertension is much lower in children and adolescents than in adults, as in the adult population, childhood obesity is strongly associated with both hypertension and prehypertension [38, 39] . The prevalence of hypertension in children and adolescents is approximately 3.5 %., and the prevalence of prehypertension is approximately 3.5 %, with higher rates of high BP in adolescents [40, 41] . Among obese children and adolescents, however, the prevalence of both hypertension and prehypertension is much higher compared to normal-weight children. This relationship is detectable even in very young children [42] . In a study by Boyd et al. [43] , high BP (prehypertension and hypertension combined) was found in 34.7 % of obese children attending a weight management clinic. Although the prevalence of high BP by race was not reported, the rate of high BP among obese children is very similar to that detected in school-based screening of generally healthy high school students as reported by Sorof et al. [44] , in which 34 % of adolescents with BMI >95th percentile had high BP. In the study by Boyd et al [43] , investigators examined clinical records and computed average BP from up to five separate visits, and also stratified the patients by moderate and severe obesity according to BMI zscore, which adjusts for age and sex. Rates of high BP were greater in obese boys than obese girls both in moderate and severely obese groups. Abnormal plasma lipid levels for HDL and triglycerides were common among all obese children. HDL <40 mg/dL was present in 49.4 % of boys with high BP, compared to 27.6 % of boys with normal BP. In girls, HDL <40 mg/dL was present in 32.9 % with high BP and in 27.6 % with normal BP. Triglyceride levels were >150 mg/dL in 34.1 % of boys with high BP compared to 25.8 % in boys with normal BP. Triglyceride levels were similar in girls with high BP (17.1 %) and normal BP (18.4 %). Although this study was conducted on a sample of obese children referred to a weight management clinic, indicating some selection for severity, the findings do indicate that, especially in boys, dyslipidemia is common among obese children with high BP. Others report that this combination of risk factors, which meet criteria for MetS, are related to atherosclerotic lesions in youth [45] and are predictive of subsequent increased carotid intima-media thickness [46] .
It is well established that cardiovascular risk factors are present in childhood, and it is also known that these risk factors set the stage for cardiovascular pathology. There are also race and ethnic differences in prevalence of individual risk factors that may explain, to some extent, the racial disparities in cardiovascular disease outcomes. Based on recent national survey data in children and adolescents, both BP levels and prevalence of high BP are increasing [47••] , and are consistently higher among minority children [48] . The increase in BP levels is largely attributable to the increase in BMI and waist circumference. Overall, black children have the highest rates of high BP and obesity; Hispanic children have highest rates of abnormal glucose levels, as well as high rates of obesity; white children have higher rates of adverse lipid levels despite lower incidence of obesity and high BP.
Birth Weight
Following original observations in adults, Barker et al. [49] proposed that low birth weight, in response to nutritional deprivation in the intrauterine environment, contributes significantly to susceptibility to cardiovascular and metabolic diseases in later life. Original reports on the birth weight hypothesis linked low birth weight to premature coronary artery disease in men, with high BP thought to be the mediating factor in evolution of cardiovascular disease. While experimental studies tend to support the theory of fetal programing in response to the intrauterine environment, this theory has been more difficult to confirm in human studies. Subsequent investigations on a potential relationship of birth weight with development of chronic disease in later life have focused on metabolic diseases. Whincup et al. [50] conducted a systematic review on published evidence from human studies on the association of birth weight and type 2 diabetes in adults. The investigators concluded that, based on the body of available data, low birth weight in most populations was inversely related to subsequent type 2 diabetes. While insulin resistance is the core metabolic alteration underlying type 2 diabetes and MetS, clinical investigations conducted on children and adolescents have resulted in inconsistent findings, largely related to variations in adiposity, rate of weight gain, and nutritional patterns, as well as modest sample sizes [19] . For example, Li et al. [51] , who investigated the effects of birth weight on insulin resistance in 139 white and black children, reported a significant association of low birth weight with higher fasting insulin, but no relationship of birth weight with insulin resistance or other metabolic or BP variables. They also detected a much stronger association of low birth weight with higher fasting insulin concentration in black children compared to white children.
Prospective studies on fetal programing that begin in the neonatal or perinatal period are limited. A recent report on a prospective study by Lurbe et al. [52••] provides new insights on the fetal programing theory. The investigators enrolled a sample of healthy newborn infants, all products of normal uncomplicated pregnancy. Birth weight and BP were measured at two days of age. The infants were then stratified into birth weight groups: small for gestational age (SGA), average for gestational age (AGA), and large for gestational age (LGA). BP and growth parameters were measured in subsequent exams at six months, two years, and five years. At age five years, a blood sample was obtained for measurement of metabolic parameters. Although the sample size of this study was modest (N=139), it did produce novel findings. Weight gain was similar in each birth weight group at each exam interval; the SGA infants remained the smallest and LGA infants remained the largest. Both current weight and weight gain were positively associated with BP, and birth weight was not significantly associated with BP. The metabolic data demonstrated higher fasting insulin levels in the SGA infants who became overweight at five years of age compared to AGA and LGA infants who became overweight at age five years. Most interesting were the measures of insulin resistance, estimated by the homeostatic model equation (HOMA index). SGA infants were insulin-resistant compared to AGA and LGA infants, regardless of their weight status at age five years of age. Even those SGA infants who remained small and thin were relatively insulin-resistant compared to those with higher birth weights. This study was limited to white children and does not provide any information on racial differences. However, the data obtained on a sample of healthy infants indicate that some perinatal factor, or combination of exposures, related to lower birth weight could program an individual for relative insulin resistance that is maintained independent of excess weight gain. Similar prospective studies that include other racial/ethnic groups of newborn infants are needed to determine if these findings are generalizable, and if so, what mechanisms initiate the perinatal programing.
Summary
Insulin resistance is the central metabolic abnormality associated with abnormal glucose metabolism, dyslipidemia, hypertension, and obesity. MetS is a clinical construct that is used to link these metabolic and cardiovascular abnormalities. Because MetS comprises multiple risk factors for type 2 diabetes and cardiovascular disease, the presence of MetS markedly increases the risk for cardiovascular morbidity and mortality. The leading clinical phenotype for MetS is obesity, and MetS is commonly detected among individuals with obesity and high BP. As with obesity, there are racial/ethnic differences in the prevalence of MetS, with higher rates among black and Hispanic populations. Risk factors within MetS are potentially modifiable by lifestyle changes in diet, physical activity, and weight reduction. In adults, additional primary prevention for adverse cardiovascular outcomes can also be achieved with pharmacologic management of hypertension, dyslipidemia, and diabetes, and some of these drugs may have insulinsensitizing benefits. For children, enduring lifestyle changes are difficult to achieve, and results of non-pharmacologic management strategies have been very limited. The use of pharmacologic treatments in MetS risk factors in children is even more complicated due to limited data on intermediate markers of cardiovascular injury and clinical trial data to support long-term benefit in arresting or reversing cardiovascular injury. Additional clinical research is needed to develop strategies on type and timing of interventions on MetS, a condition that appears to accelerate the cardiovascular disease process.
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